Apollomics Inc

Biotech Stocks Healthcare Stocks

$20.96

-0.28 (-1.32%)

As of Jun 30, 10:47 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target -40.9% upside

Low Target $7.78

Average Target $12.39

High Target $16.73

Current Price $20.96

Current
$20.96

Target
$12.39

$7.78 $12.39 avg $16.73

Scenario Analysis

Bear Case

$7.78

-62.9%

Low target

Base Case

$12.39

-40.9%

Avg target

Bull Case

$16.73

+-20.2%

High target

Risk/Reward

0.3x

Unfavorable

Price in Context

52-Week High

$42.12

-50.2% from high

52-Week Low

$3.66

+472.8% from low

Target vs 52W High

$12.39

-70.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%